Shanghai Pharmaceuticals: Injectable Cefazolin Sodium Approved Through Generic Drug Consistency Evaluation

Shanghai Pharmaceuticals has announced that its subsidiary, Shanghai Sinepharma Xinya Pharmaceutical Co., Ltd., has received from the National Medical Products Administration the “Approval Notice for a Drug Supplementary Application” for Cefazolin Sodium for Injection. The product has passed the consistency evaluation of the quality and efficacy of generic drugs.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin